Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
59.50
+0.70 (1.19%)
At close: Nov 4, 2026
| Market Cap | 6.39B +11.2% |
| Revenue (ttm) | 10.57B +24.8% |
| Net Income | 606.13M +35.3% |
| EPS | 5.60 +34.4% |
| Shares Out | 107.42M |
| PE Ratio | 10.62 |
| Forward PE | n/a |
| Dividend | 1.40 (2.35%) |
| Ex-Dividend Date | Nov 25, 2026 |
| Volume | 140,046 |
| Open | n/a |
| Previous Close | 58.80 |
| Day's Range | 58.70 - 60.10 |
| 52-Week Range | 45.50 - 78.00 |
| Beta | 0.23 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 4, 2026 |